Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$486.62 USD
+1.86 (0.38%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $487.17 +0.55 (0.11%) 6:48 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$486.62 USD
+1.86 (0.38%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $487.17 +0.55 (0.11%) 6:48 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Zacks News
Top Research Reports for Microsoft, Meta & JPMorgan Chase
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Meta Platforms, Inc. (META) and JPMorgan Chase & Co. (JPM), as well a micro-cap stock Applied Energetics, Inc. (AERG).
Integra's (IART) Q2 Earnings and Revenues Top, Margins Down
by Zacks Equity Research
Integra's (IART) second-quarter 2024 results reflect strong demand for its diverse portfolio of leading brands and the continued successful market adoption of CereLink.
Hologic (HOLX) Q3 Earnings Surpass Estimates, Margins Rise
by Zacks Equity Research
Hologic (HOLX) delivers strong performances across all its franchises in the third quarter of fiscal 2024.
3 Reasons Why You Should Hold HealthEquity (HQY) Stock Now
by Zacks Equity Research
HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.
Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Intuitive Surgical (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ICON (ICLR) Q2 Earnings Surpass Estimates, Margins Expand
by Zacks Equity Research
ICON's (ICLR) second-quarter 2024 results reflect efficient service delivery and strong cost control.
Amedisys (AMED) Q2 Earnings Top Estimates, Gross Margin Down
by Zacks Equity Research
Amedisys (AMED) delivers year-over-year growth in all three of its segmental revenues in the second quarter of 2024.
Align Technology (ALGN) Beats on Q2 Earnings, Lowers '24 Sales View
by Zacks Equity Research
Align Technology's (ALGN) records second-quarter 2024 revenue growth across all regions. This was mostly due to a robust performance by the Imaging Systems & CAD/CAM Services business segment.
Edwards Lifesciences (EW) Q2 Earnings Meet Mark, Margins Crash
by Zacks Equity Research
Edwards Lifesciences (EW) reports strong contributions from the TMTT product group in the second quarter of 2024.
Intuitive Surgical and Hooker Furnishings have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Intuitive Surgical and Hooker Furnishings are part of the Zacks Bull and Bear of the Day article.
Chemed (CHE) Q2 Earnings Miss Estimates, Margins Expand
by Zacks Equity Research
Chemed's (CHE) VITAS segment delivers impressive revenue growth and margin expansion in the second quarter of 2024.
Bull of the Day: Intuitive Surgical (ISRG)
by Tracey Ryniec
Double digit growth is back for the maker of da Vinci.
Intuitive Surgical, Inc. (ISRG) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Intuitive Surgical, Inc. (ISRG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Quest Diagnostics (DGX) Tops Q2 Earnings, Raises 2024 Outlook
by Zacks Equity Research
Quest Diagnostics (DGX) delivers impressive base business growth in the second quarter of 2024.
Are Medical Stocks Lagging Intuitive Surgical (ISRG) This Year?
by Zacks Equity Research
Here is how Intuitive Surgical, Inc. (ISRG) and biote Corp. (BTMD) have performed compared to their sector so far this year.
Intuitive Surgical (ISRG) Hits All-Time High: Will It Go Higher?
by Zacks Equity Research
Intuitive Surgical (ISRG) reported robust quarterly performance last week, and its shares touched an all-time high. Will the company's fundamentals support further upside?
Intuitive Surgical, Inc. (ISRG) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
Intuitive Surgical, Inc. (ISRG) Just Reclaimed the 50-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Intuitive Surgical (ISRG) Q2 Earnings Beat, Procedures Robust
by Zacks Equity Research
Intuitive Surgical's (ISRG) second-quarter results reflect a healthy demand for procedures. Higher pricing boosts procedure sales. An improvement in margins buoys well.
5 Non-Tech Nasdaq Stocks to Buy Amid Index's Recent Bloodbath
by Nalak Das
We have narrowed our search to five Nasdaq Composite-listed non-tech stocks. These are: COST, ISRG, IBKR, TXRH, FSLR.
Markets Book Profits; Netflix, Intuitive Beat Estimates in Q2
by Mark Vickery
Year-to-date, the Nasdaq is still +20%, the S&P +16%, the Russell +9% and the Dow +7.5%.
Compared to Estimates, Intuitive Surgical (ISRG) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Intuitive Surgical (ISRG) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Intuitive Surgical, Inc. (ISRG) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Intuitive Surgical (ISRG) delivered earnings and revenue surprises of 16.34% and 2.02%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Reasons to Add Masimo (MASI) Stock to Your Portfolio Now
by Zacks Equity Research
Masimo's (MASI) R&D activities raise optimism about the stock.
Intuitive Surgical (ISRG) Gains 26% Year to Date: Here's Why
by Zacks Equity Research
Investors are optimistic about Intuitive Surgical's (ISRG) strength in robotics.